Maxceed Capital

Maxceed Capital Group operates as a multi-family office focusing on equity investments for B2B ventures. It targets bio-medical (reproductive health, vision, medical devices) and financial technology (cybersecurity, fraud prevention). Through a co-investment model, initial capital infusions are $0.5 million to $1.5 million, seeking companies aligned with partner networks.

Established in 2018, Maxceed Capital formed as a multi-family office by twelve partners. Each contributes substantial personal assets and diverse industry expertise to nurture new businesses. General Partners Uchikata Junitsu, a private equity veteran, and Gian Chen, experienced in investment banking, jointly guide the firm’s investment strategy.

Maxceed Capital supports B2B companies seeking capital and operational guidance. Its vision cultivates successful enterprises through partners' knowledge, connections, and pragmatic support. Maxceed builds enduring relationships with portfolio companies, aligning their growth with the collective capabilities of the Group.